Abstract
With greater focus on chronic disease prevention, renewed attention has been directed toward understanding the pathophysiology of various medical conditions and the development of newer medical treatments to prevent and treat complications. There has been immense interest in evaluating societal lifestyles, cultural attitudes toward health, and dietary influences on health conditions. The omega-3 fatty acids have become a focus of interest, and recent research and trial evidence have highlighted their effects, including potential clinical advantages. Despite this progress, the precise mechanisms through which omega-3 fatty acids act remain poorly understood. These agents are now recommended as secondary prevention after acute myocardial infarction, and ongoing large clinical trials should provide insight into the use of omega-3 fatty acids in heart failure and the primary prevention of cardiovascular disease.
Similar content being viewed by others
References and Recommended Reading
USDA Nutrient Data Laboratory. Available at http://www.nalusda.gov/fnic/foodcomp. Accessed on August 1, 2007.
Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994, 1213:277–288.
Goode GK, Garcia S, Heagerty AM: Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 1997, 96:2802–2807.
McVeigh GE, Brennan GM, Cohn JN, et al.: Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1994, 14:1425–1429.
Harris WS, Rambjor GS, Windsor SL, Deirdrech D: N-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 1997, 65:459–464.
Abe Y, El-Masri B, Kimball KT, et al.: Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998, 18:723–731.
von Schacky C: n-3 PUFA in CVD: influence of cytokine polymorphism. Proc Nutr Soc 2007, 66:166–170.
De Caterina R, Liao JK, Libby P: Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000, 71(Suppl 1):213S–223S.
Johansen O, Selijeflot I, Hostmark AT: The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vas Biol 1999, 19:1681–1686.
Leaf A, Kang JX, Xiao YF, Billman GE: Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003, 107:2646–2652.
Hallaq H, Smith TW, Leaf A: Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A 1992, 89:1760–1764.
Christensen JH, Korup E, Aaroe J, et al.: Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997, 79:1670–1673.
Kinoshita I, Itoh K, Nishida-Nakai M, et al.: Antiarrhythmic effects of eicosapentaenoic acid during myocardial infarction—enhanced cardiac microsomal (Ca(2+)-Mg2+)-ATPase activity. Jpn Circ J 1994, 58:903–912.
Billman GE, Kang JX, Leaf A: Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 1997, 32:1161–1168.
Chrysohoou C, Panagiotakos DB, Pitsavos C, et al.: Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region—the ATTICA study. Am J Clin Nutr 2007, 85:1385–1391.
Rauch B, Schiele R, Schneider S, et al.: the Omega-Study group: Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study. Cardiovasc Drugs Ther 2006, 20:365–375.
Barcelli U, Glas-Greenwalt P, Pollak VE: Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects Thromb Res 1985, 39:307–312.
Shahar E, Folsom AR, Wu KK, et al.: Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993, 13:1205–1212.
Archer SL, Green D, Chamberlain M, et al.: Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arterioscler Thromb Vasc Biol 1998, 18:1119–1123.
Sanders TA, Lewis F, Slaughter S, et al.: Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70 y: the OPTILIP study. Am J Clin Nutr 2006, 84:513–522.
Lee KW, Blann AD, Lip GY: Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thromb Res 2006, 118:305–312.
Bayon Y, Croset M, Daveloose D, et al.: Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J Lipid Res 1995, 36:47–56.
Agren JJ, Vaoisaonen S, Haonninen O, et al.: Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostagland Leukot Essent Fatty Acids 1997, 57:419–421.
Mori TA, Beilin LJ, Burke V, et al.: Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997, 17:279–286.
Croset M, Lagarde M: In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets—effect on aggregation. Thromb Haemost 1986, 56:57–62.
Levine PH, Fischer M, Schneider PB, et al.: Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 1989, 149:1113–1117.
von Schacky C: n-3 PUFA in CVD: influence of cytokine polymorphism. Proc Nutr Soc 2007, 66:166–170.
Endres S, von Schacky C: n-3 polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 1996, 7:48–52
Uauy R, Mena P, Valenzuela A: Essential fatty acids as determinants of lipid requirements in infants, children and adults. Eur J Clin Nutr 1999, 53(Suppl 1):S66–S77.
Harris WS: n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65(Suppl 5):1645S–1654S.
Hau MF, Smelt AH, Bindels AJ, et al.: Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 1996, 16:1197–1202.
Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993, 88:523–533.
Ueshima H, Stamler J, Elliott P, et al.: Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure. INTERMAP Study. Hypertension 2007, 50:313–319.
Christensen JH, Gustenhoff P, Korup E, et al.: Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 1996, 312:677–678.
Hamaad A, Kaeng Lee W, Lip GY, MacFadyen RJ: Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovasc Drugs Ther 2006, 20:359–364.
Bang HO, Dyerberg J, Hjoorne N: The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976, 200:69–73.
Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312:1205–1209.
Kromhout D, Feskens EJ, Bowles CH: The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol 1995, 24:340–345.
Simon JA, Fong J, Bernert JT Jr, Browner WS: Serum fatty acids and the risk of stroke. Stroke 1995, 26:778–782.
Daviglus ML, Stamler J, Orencia AJ: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 336:1046–1053.
Zhang J, Sasaki S, Amano K, Kestleloot H: Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med 1999, 28:520–529
Hu FB, Bronner L, Willett WC, et al.: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287:1815–1821.
Guallar E, Aro A, Jimenez FJ, et al.: Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC study. Arterioscler Thromb Vasc Biol 1999, 19:1111–1118.
Kromhout D, Bloemberg BP, Feskens EJ, et al.: Alcohol, fish, fibre and antioxidant vitamins intake do not explain population differences in coronary heart disease mortality. Int J Epidemiol 1996, 25:753–759.
Ascherio A, Rimm EB, Stampfer MJ, et al.: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995, 332:977–982.
Albert CM, Hennekens CH, O’Donnell C: Fish consumption and risk of sudden cardiac death. JAMA 1998, 279:23–28.
Pietinen P, Ascherio A, Korhonen P, et al.: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997, 145:876–887.
Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989, 2:757–761.
Burr ML, Sweetham PM, Fehily AM: Diet and reinfarction. Eur Heart J 1994, 15:1152–1153
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354:447–455.
Marchioli R, Barzi F, Bomba E, et al.; GISSI-Prevenzione Investigators: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897–1903.
Singh RB, Niaz MA, Sharma JP, et al.: Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther 1997, 11:485–491.
White C: Suspected research fraud: difficulties of getting at the truth. BMJ 2005, 331:281–288.
Landmark K, Abdelnoor M, Urdal P, et al.: Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology 1998, 89:94–102.
von Schacky C, Angerer P, Kothny W, et al.: The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130:554–562.
Eritsland J, Arnesen H, Gronseth K, et al.: Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996, 77:31–36.
Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS: Preventing restenosis with fish oils following coronary angioplasty: a meta-analysis. Arch Intern Med 1993, 153:1595–1601.
Cairns JA, Gill J, Morton B, et al.: Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation 1996, 94:1553–1560.
Johansen O, Brekke M, Seljeflot I, et al.: n-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999, 33:1619–1626.
Bucher HC, Hengstler P, Schindler C, Meier G: n-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002, 112:298–304.
Hooper L, Thompson RL, Harrison RA, et al.: Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003177. DOI: 10.1002/14651858. CD003177.pub2.
Gillum RF, Mussolino ME, Madans JH: The relationship between fish consumption and stroke incidence: the NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination Survey). Arch Intern Med 1996, 156:537–542.
Iso H, Rexrode KM, Stampfer MJ: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001, 285:304–312.
Orencia AJ, Daviglus ML, Dyer AR, et al.: Fish consumption and stroke in men: 30-year findings of the Chicago Western Electric Study. Stroke 1996, 27:204–209.
Morris MC, Manson JE, Rosner B, et al.: Fish consumption and cardiovascular disease in the Physicians’ Health Study: a prospective study. Am J Epidemiol 1995, 142:166–175.
de Lorgeril M, Salen P, Martin JL, et al.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779–785.
Bemelmans WJ, Broer J, Feskens EJ, et al.: Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr 2002, 75:221–227.
Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association: Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747–2757.
Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB: Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Arch Pathol Lab Med 2005, 129:74–77.
Foran SE, Flood JG, Lewandrowski KB: Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003, 127:1603–1605.
US Environmental Protection Agency: Fish Advisories web page. Available at http://www.epa.gov/waterscience/fish. Accessed on August 1, 2007.
Weber HS, Selimi D, Huber G: Prevention of cardiovascular diseases and highly concentrated n-3 polyunsaturated fatty acids (PUFAs). Herz 2006, 31:24–30.
Lamotte M, Annemans L, Kawalec P, Zoellners Y: A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Herz 2006, 31:74–82.
McKenney JM, Sica D: Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm 2007, 64:595–605.
National Collaborating Centre for Primary Care: Post myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction. London: Royal College of General Practitioners; 2007.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kakar, P., Watson, T. & Lip, G.Y.H. New approaches to therapy with omega-3 fatty acids. Curr Atheroscler Rep 10, 79–87 (2008). https://doi.org/10.1007/s11883-008-0012-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11883-008-0012-4